Our vision at Oncofuse is to set a global standard for radioligand therapy delivery, making advanced treatments accessible, safe and sustainable for every patient who needs them.
Our mission at Oncofuse is to transform radioligand therapy into a safe, scalable, and accessible cancer treatment. Through innovative end-to-end solutions built around a single integrated packaging system for transport, administration, and waste management, we aim to reduce radiation exposure, minimize necessary manipulation steps, and optimize environmental footprint. By streamlining time-critical supply chains, we try to empower healthcare providers to deliver advanced oncological care beyond hospitals and highly specialized centers, ultimately increasing scalability and bringing hope and healing closer to patients worldwide.
We welcome inquiries from partners, investors and collaborators who share our mission to expand access to live-saving new treatments. Whether you're exploring technology partnerships, interested in investment opportunities, or simply want to learn more about our innovative Safeguard Radioligand Therapy System, we would love to hear from you!
Contact us through the contact button below. Our team will get back to you shortly.
Oncofuse is developing next-generation packaging solutions for radiopharmaceuticals that are intended to support safe, efficient, and scalable handling across the entire lifecycle – from transport and preparation to administration and waste management.
Oncofuse is developing next-generation packaging solutions for radiopharmaceuticals that are intended to support safe, efficient, and scalable handling across the entire lifecycle: from transport and preparation to administration and waste management.
The concept is based on minimizing manual interactions with radioactive materials. This design intent supports workforce safety considerations, improved environmental footprint, and a differentiated lifecycle management approach in an increasingly competitive radiopharmaceutical landscape.
By avoiding additional preparation, repackaging, or specialized handling steps, the approach is intended to simplify workflows for radiopharmaceutical medicine, pharmacy, and logistics teams. This supports more streamlined processes and contributes to scalable deployment across sites and clinical programs.

Supported by


Copyright © All Rights Reserved